Qiagen NV
Qiagen NV (QGEN) Options Open Interest
QGEN options open interest is 21,518 contracts. The 2-week average daily volume is 2,161 contracts across the chain.
Read more
Monitoring QGEN open interest helps you see where real money is positioned on Qiagen NV's options and which strikes are attracting the most commitment from traders. Qiagen NV's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor QGEN options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising QGEN options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Qiagen NV to settle.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.
It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where QGEN open interest is concentrated. Our scanner maps Qiagen NV's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Qiagen NV's options open interest as the signal it is, not as an afterthought.
| 45.00 | 1.15 | 1.75 | 1.45 | 45% | +0.4283 | 2,912 |
| 55.00 | — | 0.55 | 0.55 | 77% | +0.1393 | 1,014 |
| 50.00 | — | 2.35 | 2.35 | 104% | +0.3522 | 176 |
| 40.00 | 3.10 | 5.80 | 4.45 | 48% | +0.7944 | 5 |
| 22.50 | 19.30 | 23.20 | 21.25 | 33% | +1.0000 | 0 |
| 40.00 | 0.35 | 0.70 | 0.53 | 44% | -0.1885 | 2,854 |
| 45.00 | 2.10 | 3.70 | 2.90 | 51% | -0.5571 | 75 |
| 35.00 | — | 2.15 | 2.15 | 141% | -0.2074 | 1 |
| 22.50 | — | 2.10 | 2.10 | 290% | -0.0997 | 0 |
| 25.00 | — | 2.10 | 2.10 | 254% | -0.1148 | 0 |
As of September 23, 2026
Follow the money
Track QGEN open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→